Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. C. Schmollinger
Melanoma Inhibitor of Apoptosis Protein (ML-IAP) Is a Target for Immune-Mediated Tumor Destruction
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
X-Linked Inhibitor of Apoptosis Protein as a Therapeutic Target in Metastatic Melanoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
RIP1 Is Required for IAP Inhibitor-Mediated Sensitization of Childhood Acute Leukemia Cells to Chemotherapy-Induced Apoptosis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
TAK1 Is a Pivotal Therapeutic Target for Tumor Progression and Bone Destruction in Myeloma
Haematologica
Hematology
Inhibitor of Apoptosis (IAP) Proteins as Drug Targets for the Treatment of Cancer
F1000 Biology Reports
MOZ–TIF2-mediated Destruction of CBP/p300 Is Blocked by Calpain Inhibitor 2
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Disialoganglioside GD3 on Human Melanoma Serves as a Relevant Target Antigen for Monoclonal Antibody-Mediated Tumor Cytolysis.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Ribosomal Protein S27L Is a Direct P53 Target That Regulates Apoptosis
Oncogene
Cancer Research
Genetics
Molecular Biology
TheDrosophilaInhibitor of Apoptosis (IAP) DIAP2 Is Dispensable for Cell Survival, Required for the Innate Immune Response to Gram-Negative Bacterial Infection, and Can Be Negatively Regulated by the Reaper/Hid/Grim Family of IAP-binding Apoptosis Inducers
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
VDAC1 as a Player in Mitochondria-Mediated Apoptosis and Target for Modulating Apoptosis
Current Medicinal Chemistry
Organic Chemistry
Biochemistry
Drug Discovery
Molecular Medicine
Pharmacology
